Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Providers have much to gain from homoeopathy being accepted
| The first 150 words of the full text of this article appear below. |
EDITOR
Debates generated by the lack of evidence of benefit of
screening for breast and prostate cancer are similar to the argument
for lack of effectiveness of homoeopathy. How does one show a lack of
benefit in the face of wishful thinking by both customers and
providers, particularly when the providers have a financial interest in
a positive outcome? And, as an anaesthetist and non-user of any of
these services, why should I care?
The answer is given by Feder and Katz, who point out that patients can
be referred to homoeopathic specialists in the NHS or general
practitioners who prescribe homoeopathically.1 Consumers of these resources should have a duty to show a benefit from any consultations or treatments provided, and the fundholders should have a
duty to withhold funds in the absence of such evidence. If the
customers then wish to purchase treatment that is not beneficial they
Read all Rapid Responses
What can you learn from this BMJ paper? Read Leanne Tite's Paper+